Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.

Antineoplastic Combined Chemotherapy Protocols / therapeutic use B-Lymphocytes Child Humans Neoplasm, Residual Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis Prognosis Recurrence

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
07 2020
Historique:
received: 08 07 2019
accepted: 10 10 2019
pubmed: 12 10 2019
medline: 28 4 2021
entrez: 12 10 2019
Statut: ppublish

Résumé

ABL-class fusions other than

Identifiants

DOI: 10.3324/haematol.2019.231720 PMID: 31601692 PMC: PMC7327633
pubmed: 31601692
pii: haematol.2019.231720
doi: 10.3324/haematol.2019.231720
pmc: PMC7327633
doi:

Banques de données

ClinicalTrials.gov
['NCT00613457', 'NCT01117441']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1887-1894

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Blood. 2008 May 1;111(9):4477-89
pubmed: 18285545
Cytometry B Clin Cytom. 2018 Jan;94(1):82-93
pubmed: 28187514
Med Pediatr Oncol. 1992;20(6):497-505
pubmed: 1435520
Front Oncol. 2014 Mar 25;4:54
pubmed: 24724051
Lancet Oncol. 2012 Sep;13(9):936-45
pubmed: 22898679
Blood. 2011 Aug 25;118(8):2077-84
pubmed: 21719599
Lancet Haematol. 2018 Dec;5(12):e641-e652
pubmed: 30501871
Leukemia. 2000 Dec;14(12):2205-22
pubmed: 11187912
Hematology Am Soc Hematol Educ Program. 2003;:102-31
pubmed: 14633779
Oncotarget. 2017 Jan 17;8(3):4618-4628
pubmed: 27894077
J Clin Oncol. 2010 Nov 1;28(31):4755-61
pubmed: 20876426
J Clin Oncol. 2014 Sep 20;32(27):3012-20
pubmed: 25049327
Leukemia. 2000 Dec;14(12):2196-204
pubmed: 11187911
J Clin Oncol. 2009 Nov 1;27(31):5168-74
pubmed: 19805690
Leukemia. 2014 Jul;28(7):1467-71
pubmed: 24441288
Blood. 2010 Apr 22;115(16):3206-14
pubmed: 20154213
Blood Adv. 2017 Aug 30;1(20):1657-1671
pubmed: 29296813
Haematologica. 2013 Nov;98(11):e146-8
pubmed: 24186319
Lancet Oncol. 2009 Feb;10(2):125-34
pubmed: 19138562
N Engl J Med. 2006 Jan 12;354(2):166-78
pubmed: 16407512
Cancer Chemother Rep. 1966 Mar;50(3):163-70
pubmed: 5910392
J Clin Oncol. 2013 Sep 1;31(25):e413-6
pubmed: 23835704
Blood. 2013 Oct 10;122(15):2622-9
pubmed: 23974192
Blood. 2017 Jun 22;129(25):3352-3361
pubmed: 28408464
Am Soc Clin Oncol Educ Book. 2015;:e352-9
pubmed: 25993196
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
J Clin Oncol. 2018 Aug 1;36(22):2306-2314
pubmed: 29812996
Leukemia. 2007 Apr;21(4):604-11
pubmed: 17287850
Haematologica. 2015 Jul;100(7):e261-4
pubmed: 25769542
Blood. 2016 Apr 28;127(17):2101-12
pubmed: 26888258
Blood. 2007 Feb 1;109(3):896-904
pubmed: 17003366
Blood. 2010 Dec 2;116(23):4874-84
pubmed: 20699438
Haematologica. 2019 Jan;104(1):e13-e16
pubmed: 30213832
J Clin Oncol. 2009 Nov 1;27(31):5175-81
pubmed: 19805687
Blood. 2015 Jun 25;125(26):3977-87
pubmed: 25999453
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766

Auteurs

Gunnar Cario (G)

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany gunnar.cario@uksh.de.

Veronica Leoni (V)

Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.

Valentino Conter (V)

Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.

Andishe Attarbaschi (A)

St. Anna Kinderspital and Children's Cancer Research Institute, Vienna, Austria.

Marketa Zaliova (M)

CLIP, Department of Pediatric Hematology and Oncology, 2Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Lucie Sramkova (L)

CLIP, Department of Pediatric Hematology and Oncology, 2Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Gianni Cazzaniga (G)

Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.

Grazia Fazio (G)

Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.

Rosemary Sutton (R)

Molecular Diagnostics, Children's Cancer Institute, University of NSW, Sydney, NSW, Australia.

Sarah Elitzur (S)

Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Israel.

Shai Izraeli (S)

Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Israel.

Melchior Lauten (M)

Pediatrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Franco Locatelli (F)

Department of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS) Childrens' Hospital Bambino Gesù, Sapienza, University of Rome, Rome, Italy.

Giuseppe Basso (G)

IIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy.

Barbara Buldini (B)

IIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy.

Anke K Bergmann (AK)

Department of Human Genetics, Medical School Hannover, Hannover, Germany.

Jana Lentes (J)

Department of Human Genetics, Medical School Hannover, Hannover, Germany.

Doris Steinemann (D)

Department of Human Genetics, Medical School Hannover, Hannover, Germany.

Gudrun Göhring (G)

Department of Human Genetics, Medical School Hannover, Hannover, Germany.

Brigitte Schlegelberger (B)

Department of Human Genetics, Medical School Hannover, Hannover, Germany.

Oskar A Haas (OA)

St. Anna Kinderspital and Children's Cancer Research Institute, Vienna, Austria.

Denis Schewe (D)

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Swantje Buchmann (S)

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Anja Moericke (A)

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Deborah White (D)

Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.

Tamas Revesz (T)

Women's and Children's Hospital, SA Pathology, University of Adelaide, Adelaide, Australia.

Martin Stanulla (M)

Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.

Georg Mann (G)

St. Anna Kinderspital and Children's Cancer Research Institute, Vienna, Austria.

Nicole Bodmer (N)

University Children's Hospital Zurich, Zurich, Switzerland.

Nira Arad-Cohen (N)

Pediatric Hematology-Oncology Department, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Jan Zuna (J)

CLIP, Department of Pediatric Hematology and Oncology, 2Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Maria Grazia Valsecchi (MG)

Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.

Martin Zimmermann (M)

Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.

Martin Schrappe (M)

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Andrea Biondi (A)

Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Protocoles de polychimiothérapie antinéoplasique › Relapses and treatment-related events...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes B › Relapses and treatment-related events...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Relapses and treatment-related events...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Relapses and treatment-related events...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Maladie résiduelle › Relapses and treatment-related events...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Leucémie lymphoïde › Leucémie-lymphome lymphoblastique à précurseurs B et T › Leucémie-lymphome lymphoblastique à précurseurs B › Relapses and treatment-related events...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Leucémie lymphoïde › Leucémie-lymphome lymphoblastique à précurseurs B et T › Relapses and treatment-related events...
questionsmedicales.fr › Diagnostic › Pronostic › Relapses and treatment-related events...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Récidive › Relapses and treatment-related events...